Company Filing History:
1 out of 1,500 
1 out of 271 
Years Active: 2024
Title: Maria Astrid Ölwegård-Halvarsson: Innovator in GLP-1 Receptor Research
Introduction
Maria Astrid Ölwegård-Halvarsson is a prominent inventor based in Mölndal, Sweden. She has made significant contributions to the field of biochemistry, particularly in the development of compounds targeting the GLP-1 receptor. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.
Latest Patents
Maria holds a patent for "GLP-1 receptor ligand moiety conjugated oligonucleotides and uses thereof." This patent provides compounds and methods for targeting cells that express the GLP-1 receptor. The implications of her work are substantial, as it opens new avenues for therapeutic interventions in metabolic disorders.
Career Highlights
Throughout her career, Maria has worked with notable companies such as AstraZeneca AB and Ionis Pharmaceuticals, Inc. Her experience in these leading pharmaceutical firms has equipped her with the skills and knowledge necessary to drive innovation in her field.
Collaborations
Maria has collaborated with esteemed colleagues, including Brett P. Monia and Thazha P. Prakash. These partnerships have further enriched her research and contributed to the success of her projects.
Conclusion
Maria Astrid Ölwegård-Halvarsson is a trailblazer in the realm of GLP-1 receptor research, with a patent that underscores her innovative spirit. Her work continues to influence the development of new therapeutic strategies, making her a key figure in the scientific community.